These findings not only demonstrate the potential of the SINV-GM-CSF mutant as a replicable oncolytic virus, but also provide a basis for future studies of the SINV as well as other Alphaviruses for the treatment of hepatocellular carcinoma. Here, CSF2 is linked to hepatocellular carcinoma.